These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26383726)

  • 1. Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.
    Morris PB; Ference BA; Jahangir E; Feldman DN; Ryan JJ; Bahrami H; El-Chami MF; Bhakta S; Winchester DE; Al-Mallah MH; Sanchez Shields M; Deedwania P; Mehta LS; Phan BA; Benowitz NL
    J Am Coll Cardiol; 2015 Sep; 66(12):1378-91. PubMed ID: 26383726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cohort study of electronic cigarette use: effectiveness and safety at 24 months.
    Manzoli L; Flacco ME; Ferrante M; La Vecchia C; Siliquini R; Ricciardi W; Marzuillo C; Villari P; Fiore M;
    Tob Control; 2017 May; 26(3):284-292. PubMed ID: 27272748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electronic cigarettes: a policy statement from the American Heart Association.
    Bhatnagar A; Whitsel LP; Ribisl KM; Bullen C; Chaloupka F; Piano MR; Robertson RM; McAuley T; Goff D; Benowitz N;
    Circulation; 2014 Oct; 130(16):1418-36. PubMed ID: 25156991
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiovascular effects of electronic cigarettes.
    Benowitz NL; Fraiman JB
    Nat Rev Cardiol; 2017 Aug; 14(8):447-456. PubMed ID: 28332500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing tobacco use: the neglected cardiovascular disease risk factor.
    Rigotti NA; Clair C
    Eur Heart J; 2013 Nov; 34(42):3259-67. PubMed ID: 24014389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electronic cigarettes and cardiovascular risk: hype or up in smoke?
    Nelluri BK; Murphy K; Mookadam F
    Future Cardiol; 2015 May; 11(3):271-3. PubMed ID: 26021631
    [No Abstract]   [Full Text] [Related]  

  • 7. Are e-cigarettes beneficial for public health: Hume's guillotine - The debate continues?
    Mishra S
    Indian Heart J; 2017; 69(6):810-813. PubMed ID: 29174270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco Control and Treatment for the Pediatric Clinician: Practice, Policy, and Research Updates.
    Jenssen BP; Wilson KM
    Acad Pediatr; 2017 Apr; 17(3):233-242. PubMed ID: 28069410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between tobacco control policies, consumption of rolled tobacco and e-cigarettes, and intention to quit conventional tobacco, in Europe.
    Lidón-Moyano C; Martín-Sánchez JC; Saliba P; Graffelman J; Martínez-Sánchez JM
    Tob Control; 2017 Mar; 26(2):149-152. PubMed ID: 26888824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine and the Developing Human: A Neglected Element in the Electronic Cigarette Debate.
    England LJ; Bunnell RE; Pechacek TF; Tong VT; McAfee TA
    Am J Prev Med; 2015 Aug; 49(2):286-93. PubMed ID: 25794473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescents' beliefs about the risks involved in smoking "light" cigarettes.
    Kropp RY; Halpern-Felsher BL
    Pediatrics; 2004 Oct; 114(4):e445-51. PubMed ID: 15466070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tobacco smoke and cardiovascular risk: a call for continued efforts to reduce exposure.
    Frey P; Waters DD
    Curr Opin Cardiol; 2011 Sep; 26(5):424-8. PubMed ID: 21730825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global youth tobacco surveillance, 2000-2007.
    Warren CW; Jones NR; Peruga A; Chauvin J; Baptiste JP; Costa de Silva V; el Awa F; Tsouros A; Rahman K; Fishburn B; Bettcher DW; Asma S;
    MMWR Surveill Summ; 2008 Jan; 57(1):1-28. PubMed ID: 18219269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing cigarette, 1950-1995.
    Hoffmann D; Hoffmann I
    J Toxicol Environ Health; 1997 Mar; 50(4):307-64. PubMed ID: 9120872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force.
    Patnode CD; Henderson JT; Thompson JH; Senger CA; Fortmann SP; Whitlock EP
    Ann Intern Med; 2015 Oct; 163(8):608-21. PubMed ID: 26389650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the nicotine content of combusted tobacco products sold in New Zealand.
    Donny EC; Walker N; Hatsukami D; Bullen C
    Tob Control; 2017 Mar; 26(e1):e37-e42. PubMed ID: 27672126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging nicotine delivery products. Implications for public health.
    Benowitz NL
    Ann Am Thorac Soc; 2014 Feb; 11(2):231-5. PubMed ID: 24575992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease.
    Bullen C
    Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):883-95. PubMed ID: 18570625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.